MARC record from Internet Archive

LEADER: 04847cam 22008054a 4500
001 ocm44877855
003 OCoLC
005 20200523015243.0
008 000818s2001 paua b 001 0 eng
010 $a 00063240
040 $aDNLM/DLC$beng$cDLC$dNLM$dAZA$dVAM$dBAKER$dNLGGC$dBTCTA$dYDXCP$dU3Q$dOCLCG$dUKM$dZWZ$dIG#$dOCLCF$dOCLCQ$dOCLCO$dOCLCQ
015 $aGBA1V1772$2bnb
016 7 $a100962898$2DNLM
019 $a48110939$a490806396
020 $a1560534583$q(alk. paper)
020 $a9781560534587$q(alk. paper)
035 $a(OCoLC)44877855$z(OCoLC)48110939$z(OCoLC)490806396
042 $apcc
050 00 $aRC685.C6$bE85 2001
060 00 $a2001 D-067
060 10 $aWG 300$bE89 2001
082 00 $a616.1/2306$221
084 $a44.85$2bcl
245 00 $aEvidence-based management of the acute coronary syndrome /$cedited by Roque Pifarré, Patrick J. Scanlon.
260 $aPhiladelphia :$bHanley & Belfus,$c©2001.
300 $axiii, 477 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $a1. Pathophysiology of the acute coronary syndrome -- 2. Clinical presentation and diagnosis (including Triggering) -- 3. Risk factor stratification and acute coronary syndromes -- 4. Antiplatelet agents in acute coronary syndromes -- 5. Heparin in acute coronary syndromes -- 6. Low-molecular-weight heparins in acute coronary syndromes -- 7. Antithrombin agents: the new class of antithrombotic drugs -- 8. Thrombolytic therapy in acute coronary syndrome -- 9. Oral anticoagulation in acute coronary syndromes -- 10. Beta blockers in acute coronary syndromes -- 11. Calcium antagonists for the acute coronary syndromes -- 12. Nitrates in the acute coronary syndromes -- 13. Antiarrhythmic therapy in the management of acute coronary syndromes -- 14. The use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the acute coronary syndrome -- 15. Other pharmacologic agents for acute coronary syndromes -- 16. Role of coronary angiography in the evaluation of patients with acute coronary syndromes -- 17. The essential role of percutaneous coronary interventions in the management of acute coronary syndromes -- 18. Surgical intervention for acute coronary syndromes -- 19. Anesthetic considerations for patients with acute myocardial infarction undergoing cardiac surgery -- 20. Myocardial protection for patients with acute evolving myocardial infarction undergoing cardiac surgery -- 21. Mechanical support for patients with acute coronary syndromes -- 22. Left ventricular free wall rupture complicating acute myocardial infarction -- 23. Ventricular septal rupture secondary to acute myocardial infarction -- 24. Repair of left ventricular aneurysm -- 25. Surgery for ischemic mitral regurgitation.
650 0 $aCoronary heart disease.
650 0 $aEvidence-based medicine.
650 12 $aMyocardial Infarction$xdrug therapy.
650 22 $aMyocardial Infarction$xsurgery.
650 22 $aMyocardial Ischemia$xdrug therapy.
650 22 $aMyocardial Ischemia$xsurgery.
650 22 $aAngina, Unstable$xdrug therapy.
650 22 $aAngina, Unstable$xsurgery.
650 6 $aArtères coronaires$xMaladies.
650 6 $aMédecine factuelle.
650 17 $aInfarctus du myocarde$xtraitement médicamenteux.$2fmesh
650 27 $aAngor instable$xtraitement médicamenteux.$2fmesh
650 27 $aAngor instable$xchirurgie.$2fmesh
650 27 $aInfarctus du myocarde$xchirurgie.$2fmesh
650 27 $aIschémie myocardique$xtraitement médicamenteux.$2fmesh
650 27 $aIschémie myocardique$xchirurgie.$2fmesh
650 7 $aMédecine fondée sur la preuve.$2fmesh
650 7 $aCoronary heart disease.$2fast$0(OCoLC)fst00879535
650 7 $aEvidence-based medicine.$2fast$0(OCoLC)fst00917247
650 17 $aCoronaire hartziekten.$2gtt
650 17 $aTherapieën.$2gtt
650 7 $aMaladies coronariennes.$2ram
650 7 $aMédecine basée sur la preuve.$2ram
700 1 $aPifarré, Roque.
700 1 $aScanlon, Patrick J.,$d1938-
776 08 $iOnline version:$tEvidence-based management of the acute coronary syndrome.$dPhiladelphia : Hanley & Belfus, ©2001$w(OCoLC)606590481
938 $aBaker & Taylor$bBKTY$c69.00$d69.00$i1560534583$n0003631763$sactive
938 $aBaker and Taylor$bBTCP$n00063240
938 $aIngram$bINGR$n9781560534587
938 $aYBP Library Services$bYANK$n1740828
029 1 $aAU@$b000022569157
029 1 $aAU@$b000023115160
029 1 $aNLGGC$b216309506
029 1 $aNLM$b100962898
029 1 $aNZ1$b6199536
029 1 $aYDXCP$b1740828
029 1 $aZWZ$b060507845
994 $aZ0$bP4A
948 $hHELD BY P4A - 151 OTHER HOLDINGS